To include your compound in the COVID-19 Resource Center, submit it here.

Dovitinib lactate: Phase II data

Data from 59 patients in the Phase II portion of an open-label, international Phase I/II trial showed that once-daily 500 mg oral

Read the full 227 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE